Core Viewpoint - Growth investors are attracted to stocks with above-average financial growth, but identifying such stocks can be challenging due to inherent risks and volatility [1] Group 1: Company Overview - Woori Bank (WF) is currently recommended as a growth stock by the Zacks Growth Style Score system, which evaluates a company's growth prospects beyond traditional metrics [2] - The bank holds a favorable Growth Score and a top Zacks Rank, indicating strong potential for growth investors [2] Group 2: Earnings Growth - Historical EPS growth for Woori Bank is 4.7%, but projected EPS growth for this year is 16.7%, surpassing the industry average of 14% [4] - Earnings growth is crucial for growth investors, with double-digit growth being a strong indicator of future stock price gains [3] Group 3: Cash Flow Growth - Woori Bank's year-over-year cash flow growth is 13.4%, significantly higher than the industry average of 6.2% [5] - The bank's historical annualized cash flow growth rate over the past 3-5 years is 7.5%, compared to the industry average of 6% [6] Group 4: Earnings Estimate Revisions - The current-year earnings estimates for Woori Bank have increased by 7.8% over the past month, indicating a positive trend in earnings estimate revisions [7] - A positive trend in earnings estimate revisions is correlated with near-term stock price movements, making it an important factor for investors [7] Group 5: Investment Potential - Woori Bank has achieved a Zacks Rank of 2 and a Growth Score of B, suggesting it is a potential outperformer and a solid choice for growth investors [9]

Core Insights - Encompass Health Corporation is a leading provider of inpatient rehabilitation services in the U.S., recognized for its clinical quality and capital management, with a focus on sustainable double-digit EBITDA growth driven by demographic trends and regulatory barriers [1] Financial Performance - In Q4 2025, Encompass Health reported an adjusted EPS of $1.46, reflecting a 24.8% increase year-over-year and exceeding the Zacks Consensus Estimate by 13.2% [3] - The company's net operating revenues reached $1.5 billion, representing a 9.9% year-over-year growth, attributed to higher net revenue per discharge and an increase in discharges [3] Financial Metrics - Encompass Health has a P/E ratio of 19.29, indicating that investors are willing to pay $19.29 for every dollar of earnings [4] - The price-to-sales ratio stands at 1.85, and the enterprise value to sales ratio is 1.88, reflecting the market's valuation of the company [4] - The company maintains a low debt-to-equity ratio of 0.08, showcasing a conservative leverage approach that enhances financial resilience [4] Operational Strength - The company owns 79% of its real estate, which supports its operational leverage and efficient hospital development [5] - Encompass Health's current ratio is 1.08, indicating its capability to meet short-term liabilities [5] - The company is recognized as a strong growth stock, with Zacks Style Scores assisting investors in identifying stocks with high short-term market outperformance potential [5]

Core Viewpoint - Growth stocks are appealing due to their potential for above-average financial growth, but identifying those that can fulfill their potential is challenging due to associated risks and volatility [1] Group 1: Company Overview - StoneX Group Inc. (SNEX) is recommended as a promising growth stock, possessing a favorable Growth Score and a top Zacks Rank [2] Group 2: Earnings Growth - Historical EPS growth rate for StoneX Group is 22.5%, with projected EPS growth of 34.1% this year, surpassing the industry average of 19.6% [5] Group 3: Cash Flow Growth - Year-over-year cash flow growth for StoneX Group is 20.2%, significantly higher than the industry average of -1.7% [6] - The company's annualized cash flow growth rate over the past 3-5 years is 27.9%, compared to the industry average of 11.2% [7] Group 4: Earnings Estimate Revisions - Current-year earnings estimates for StoneX Group have been revised upward, with the Zacks Consensus Estimate increasing by 8.2% over the past month [9] Group 5: Conclusion - StoneX Group has achieved a Growth Score of B and a Zacks Rank 1, indicating it is a potential outperformer and a solid choice for growth investors [11]

Core Viewpoint - Investors are increasingly seeking growth stocks that demonstrate above-average growth potential, with Wesco International (WCC) being highlighted as a strong candidate due to its favorable growth metrics and Zacks Rank [2][11]. Earnings Growth - Wesco International has a historical EPS growth rate of 14.7%, with projected EPS growth of 18.2% for the current year, surpassing the industry average of 17.1% [5][4]. Asset Utilization Ratio - The company has an asset utilization ratio (sales-to-total-assets ratio) of 1.45, indicating it generates $1.45 in sales for every dollar in assets, which is higher than the industry average of 1.35 [7][6]. - Wesco's sales are expected to grow by 5.7% this year, compared to the industry average of 4.6% [7]. Earnings Estimate Revisions - There has been a positive trend in earnings estimate revisions for Wesco International, with the Zacks Consensus Estimate for the current year increasing by 0.2% over the past month [9][8]. Overall Assessment - Wesco International holds a Zacks Rank of 2 (Buy) and a Growth Score of B, indicating it is a potential outperformer and a solid choice for growth investors [11].

Core Viewpoint - The article highlights Patria Investments (PAX) as a promising growth stock, supported by its favorable Growth Score and Zacks Rank, indicating strong potential for outperformance in the market [2][10]. Earnings Growth - Patria Investments has a historical EPS growth rate of 8.8%, but the projected EPS growth for this year is significantly higher at 21.7%, surpassing the industry average of 12.3% [4]. Asset Utilization Ratio - The company has an asset utilization ratio (sales-to-total-assets ratio) of 0.28, indicating it generates $0.28 in sales for every dollar in assets, which is more efficient than the industry average of 0.23 [5]. Sales Growth - Patria Investments is expected to achieve a sales growth of 14.7% this year, compared to the industry average of 7.9%, showcasing its strong sales performance [6]. Earnings Estimate Revisions - The current-year earnings estimates for Patria Investments have been revised upward, with the Zacks Consensus Estimate increasing by 1.6% over the past month, indicating positive momentum [8]. Overall Positioning - With a Growth Score of B and a Zacks Rank of 2, Patria Investments is well-positioned for potential outperformance, making it an attractive option for growth investors [10].

Core Viewpoint - Growth investors are attracted to stocks with above-average financial growth, but identifying such stocks can be challenging due to their inherent risks and volatility [1] Group 1: Growth Stock Identification - The Zacks Growth Style Score simplifies the process of finding promising growth stocks by analyzing a company's real growth prospects beyond traditional metrics [2] - Banco Bilbao (BBVA) is currently recommended due to its favorable Growth Score and top Zacks Rank [2] Group 2: Earnings Growth - Earnings growth is a critical factor for growth investors, with double-digit growth being particularly desirable as it indicates strong future prospects [4] - Banco Bilbao has a historical EPS growth rate of 33.3%, with projected EPS growth of 18.9% this year, surpassing the industry average of 13.5% [5] Group 3: Cash Flow Growth - High cash flow growth is essential for growth-oriented companies, allowing them to fund new projects without relying on external financing [6] - Banco Bilbao's year-over-year cash flow growth is 23%, significantly higher than the industry average of 6.5% [6] - The company's annualized cash flow growth rate over the past 3-5 years is 11.7%, compared to the industry average of 6% [7] Group 4: Earnings Estimate Revisions - Positive trends in earnings estimate revisions are correlated with stock price movements, making them an important consideration for investors [8] - The current-year earnings estimates for Banco Bilbao have increased by 17.7% over the past month [8] Group 5: Overall Positioning - Banco Bilbao has achieved a Zacks Rank of 2 and a Growth Score of B, positioning it well for potential outperformance in the market [10]

Core Viewpoint - Growth investors are increasingly focused on identifying stocks with above-average financial growth, which can lead to solid returns, but finding such stocks is challenging due to their inherent risks and volatility [1] Group 1: Company Overview - Fabrinet (FN) is currently highlighted as a promising growth stock, supported by a favorable Growth Score and a top Zacks Rank [2] - The company specializes in assembling optical, electro-mechanical, and electronic devices for other firms [3] Group 2: Earnings Growth - Fabrinet has a historical EPS growth rate of 23.7%, with projected EPS growth of 33.6% for the current year, significantly surpassing the industry average of 23.9% [5] Group 3: Cash Flow Growth - The year-over-year cash flow growth for Fabrinet stands at 12.6%, outperforming the industry average of -5.3% [6] - Over the past 3-5 years, the company's annualized cash flow growth rate has been 20.6%, compared to the industry average of 5.2% [7] Group 4: Earnings Estimate Revisions - There has been a positive trend in earnings estimate revisions for Fabrinet, with the Zacks Consensus Estimate for the current year increasing by 2.5% over the past month [8] Group 5: Investment Positioning - Fabrinet's combination of a Zacks Rank 1 and a Growth Score of B positions it well for potential outperformance, making it an attractive option for growth investors [10]

Growth investors focus on stocks that are seeing above-average financial growth, as this feature helps these securities garner the market's attention and deliver solid returns. But finding a growth stock that can live up to its true potential can be a tough task.In addition to volatility, these stocks carry above-average risk by their very nature. Also, one could end up losing from a stock whose growth story is actually over or nearing its end.However, the Zacks Growth Style Score (part of the Zacks Style S ...

Core Viewpoint - Investors are increasingly seeking growth stocks that demonstrate above-average growth potential, with Infineon Technologies AG identified as a strong candidate due to its favorable growth metrics and Zacks Rank [2][11]. Earnings Growth - Infineon Technologies has a historical EPS growth rate of 12%, but projected EPS growth for this year is significantly higher at 21.8%, surpassing the industry average of 20.6% [4]. Asset Utilization Ratio - The company has an asset utilization ratio (sales-to-total-assets ratio) of 0.52, indicating it generates $0.52 in sales for every dollar in assets, which is more efficient than the industry average of 0.51 [6]. Sales Growth - Infineon Technologies is expected to achieve a sales growth of 15% this year, compared to the industry average of 10.1%, highlighting its strong sales performance [7]. Earnings Estimate Revisions - There has been a positive trend in earnings estimate revisions for Infineon Technologies, with the Zacks Consensus Estimate for the current year increasing by 3.6% over the past month [9]. Overall Positioning - With a Zacks Rank of 2 (Buy) and a Growth Score of B, Infineon Technologies is well-positioned for potential outperformance, making it an attractive option for growth investors [11].

Investors seek growth stocks to capitalize on above-average growth in financials that help these securities grab the market's attention and produce exceptional returns. However, it isn't easy to find a great growth stock.In addition to volatility, these stocks carry above-average risk by their very nature. Also, one could end up losing from a stock whose growth story is actually over or nearing its end.However, the Zacks Growth Style Score (part of the Zacks Style Scores system), which looks beyond the trad ...